Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine.

Ungerechts, Guy; Springfeld, Christoph; Frenzke, Marie E; Lampe, Johanna; Johnston, Patrick B; Parker, William B; Sorscher, Eric J; Cattaneo, Roberto

Ungerechts, Guy; Springfeld, Christoph; Frenzke, Marie E; Lampe, Johanna; Johnston, Patrick B; Parker, William B; Sorscher, Eric J; Cattaneo, Roberto.

Affiliation

Ungerechts G; Molecular Medicine Program and Virology and Gene Therapy Track, Mayo Clinic College of Medicine, Rochester, Minnesota 55902, USA.

Cancer Res ; 67(22): 10939-47, 2007 Nov 15.

Article in En | MEDLINE | ID: mdl-18006839

Subject(s)

Antigens, CD20/biosynthesis; Lymphoma/drug therapy; Lymphoma/metabolism; Measles virus/metabolism; Vidarabine/analogs & derivatives; Animals; Antineoplastic Agents/pharmacology; Chlorocebus aethiops; Drug Therapy/methods; Humans; Membrane Cofactor Protein/biosynthesis; Mice; Mice, Transgenic; Prodrugs/pharmacology; Purine-Nucleoside Phosphorylase/metabolism; Vero Cells; Vidarabine/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Antigens, CD20 / Lymphoma / Measles virus Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2007 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links